Dr. Palmer's drawing of a liver lobule was the winner of the 2012 EASL Journal of Hepatology cover contest.
|
Welcome to liverdisease.com The Home Page of Melissa Palmer, MD Melissa Palmer, MD is currently available for lecturing, investor and hedge-fund consultations, consultations to industry, and media interviews and appearances-- including television. Dr. Palmer is also available as an expert witness hepatologist or as a liver disease expert witness. For any of the above-mentioned matters, Melissa Palmer, MD can be contacted through hepatitismedia@gmail.com. This e-mail address may not be used for personal medical questions or advice.
CLICK HERE TO VIEW MELISSA PALMER MD'S YOUTUBE VIDEOS ON THE NEW PROTEASE INHIBITORS.
CLICK THE LINKS BELOW TO VIEW MELISSA PALMER M.D.'S MOST RECENT ARTICLES ON TREATING HEPATITIS C 1. Introduction to Treating Hepatitis C with Protease Inhibitors 2. Treating Hepatitis C With Protease Inhibitors-- the New Standard of Care 3. The Future of Hepatitis C Beyond Protease Inhibitors-- Will Hepatitis C be a disease of the past? 4. The Impact of Exercise and Nutrition on the Outcome of Patients with Chronic Hepatitis C
|
|||||||||||||||||||||||||||||||||
 |
|||||||||||||||||||||||||||||||||
| Check out Dr. Palmer's WebMD Hepatitis Exchange Page! | |||||||||||||||||||||||||||||||||
 |
|||||||||||||||||||||||||||||||||
 |
|||||||||||||||||||||||||||||||||
 |
|||||||||||||||||||||||||||||||||
 |
|||||||||||||||||||||||||||||||||
 |
|||||||||||||||||||||||||||||||||
 |
|||||||||||||||||||||||||||||||||
 |
|||||||||||||||||||||||||||||||||
| WATCH PART 2 of -LIFESTYLE ISSUES AND HEPATITIS C | |||||||||||||||||||||||||||||||||
|
Click here to learn about Ribapak for the treatment of HCV - from Three Rivers Pharmaceuticals
PODCAST BY DR. PALMER ON HBV !!
Click here for Dr. Palmer's audio presentation on : the management of hepatic encephalopathy/ brain fog
Strategies for minimizing fatigue Recreational drugs and the liver CLICK HERE to learn about "Loving Joe Gallucci", a new book written by Kate Genovese, RN (foreward by Melissa Palmer, M.D.), which does an excellent job of portraying the human drama which flows from a diagnosis of liver disease. CLICK HERE for the bibliography of the revised edition of "Dr. Melissa Palmer's Guide to Hepatitis & Liver Disease." Dr. Palmer is an internationally renowned hepatologist who has been practicing medicine since 1985. Prior to 2012, she maintained perhaps the largest medical practice devoted to liver disease in the United States. Dr. Palmer is Clinical Professor of Medicine at New York University Medical Center. Dr. Palmer graduated from Columbia University with a B.A. and was trained in hepatology (as well as medical school) at the Mount Sinai School of Medicine in New York City. Dr. Palmer is Board Certified in Gastroenterology and in Internal Medicine. She has authored numerous scientific publications in the field of hepatology in such peer-reviewed journals as Hepatology, Gastroenterology, Seminars of Liver Disease, Transplantation and Archives of Internal Medicine. She is frequently called upon by the media for her opinion on various topics related to liver disease. Dr. Palmer has appeared many times on television as a liver disease expert and has been quoted in such publications as TIME magazine, Cosmopolitan magazine, Prevention magazine, the Los Angeles Times, and Newsday. She also has appeared in numerous videos and CD-Roms aimed at educating doctors and the public about hepatitis C and other liver diseases, such as primary biliary cirrhosis. Dr. Palmer lectures to the medical and general public on liver disease-related topics on a regular basis. Dr. Palmer has performed numerous clinical trials on various experimental medications for the treatment of hepatitis. Dr. Palmer is currently available for lecturing, investor and hedge-fund consultations, consultations to industry, and media interviews and appearances-- including television. Dr. Palmer is also available as an expert witness hepatologist or as a liver disease expert witness. For any of the above-mentioned matters, she can be contacted through hepatitismedia@gmail.com.
WEB SITE DESIGN BY SMART CATS
BREAKING NEWS!-- ON MAY 13,2011 THE FDA APPROVED THE PROTEASE INHIBITOR BOCEPREVIR FOR TREATING HEPATITIS C. BOCEPREVIR WILL BE MARKETED BY MERCK UNDER THE BRAND NAME "VICTRELIS". ON MAY 23, 2011, THE FDA APPROVED THE PROTEASE INHIBITOR TELAPREVIR FOR TREATING HEPATITIS C. TELAPREVIR WILL BE MARKETED BY VERTEX PHARMACEUTICALS UNDER THE BRAND NAME "INCIVEK".
GO TO THE "PROTEASE INHIBITORS FOR TREATING HEPATITIS C" PAGE PROTEASE INHIBITORS ARE A MAJOR ADVANCE IN TREATING HEPATITIS C.
|
|||||||||||||||||||||||||||||||||
